• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    3/16/23 1:56:50 PM ET
    $AMBI
    $BUR
    $CABA
    $CERT
    Environmental Services
    Industrials
    Finance: Consumer Services
    Finance
    Get the next $AMBI alert in real time by email

    Gainers

    • Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for hemorrhagic cystitis.
    • PureCycle Technologies, Inc. (NASDAQ:PCT) rose 31.8% to $6.29 after the company issued Q4 update.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares jumped 30.7% to $5.48. ThermoGenesis shares jumped around 99% on Wednesday after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.
    • Science 37 Holdings, Inc. (NASDAQ:SNCE) gained 27.1% to $0.3083.
    • EverCommerce Inc. (NASDAQ:EVCM) jumped 21.2% to $10.86 following Q4 results.
    • Wejo Group Limited (NASDAQ:WEJO) gained 17.7% to $0.4001.
    • Verde Clean Fuels, Inc. (NASDAQ:VGAS) jumped 17.1% to $9.25.
    • Celyad Oncology SA (NASDAQ:CYAD) gained 16.1% to $0.9599. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.
    • UiPath Inc. (NYSE:PATH) rose 15.8% to $16.95 after the company reported better-than-expected Q4 results and issued strong revenue guidance.
    • PagerDuty, Inc. (NYSE:PD) gained 15.6% to $32.19 after the company reported better-than-expected Q4 EPS and sales results and issued Q1 and FY24 adjusted EPS guidance above estimates.
    • CIRCOR International, Inc. (NYSE:CIR) jumped 15% to $30.75. Circor International posted upbeat quarterly results on Wednesday.
    • MacroGenics, Inc. (NASDAQ:MGNX) jumped 14.5% to $7.26 after posting Q4 results.
    • EverCommerce Inc. (NASDAQ:EVCM) gained 14.3% to $10.24 following Q4 results.
    • JanOne Inc. (NASDAQ:JAN) gained 14% to $1.62. JanOne announced that on March 9, 2023, that it entered into a stock purchase agreement with buyer VM7 Corporation.
    • Femasys Inc. (NASDAQ:FEMY) jumped 13.8% to $0.9682.
    • Nocera, Inc. (NASDAQ:NCRA) gained 13.7% to $1.16.
    • Designer Brands Inc. (NYSE:DBI) jumped 13.6% to $9.41 after posting a profit for the fourth quarter.
    • Genelux Corporation (NASDAQ:GNLX) rose 13.1% to $21.38.
    • Legacy Housing Corporation (NASDAQ:LEGH) gained 10.2% to $21.75 following upbeat quarterly results.
    • Certara, Inc. (NASDAQ:CERT) climbed 8.5% to $22.33 after it was announced the company will join the S&P SmallCap 600.

    Losers

    • Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares dipped 53.4% to $1.85 after the company reported a disagreement with one of its partners over certain milestone payments.
    • LivePerson, Inc. (NASDAQ:LPSN) fell 52.9% to $4.60 after the company reported worse-than-expected Q4 sales results and issued Q1 and FY23 revenue guidance below estimates.
    • Proterra Inc. (NASDAQ:PTRA) dropped 46.6% to $1.34 after the company reported worse-than-expected Q4 results and issued FY23 revenue guidance below estimates.
    • Fluent, Inc. (NASDAQ:FLNT) fell 42% to $0.6685 after the company reported worse-than-expected Q4 sales results.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) dipped 38.8% to $1.07.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) fell 34.5% to $0.6611 after the company announced a company-wide operational pause in order to conserve capital while it conducts discussions with potential funding sources and explores strategic opportunities.
    • First Republic Bank (NYSE:FRC) dropped 33.5% to $20.73 amid continued downward momentum in the sector following recent bank failures.
    • Loyalty Ventures Inc. (NASDAQ:LYLT) fell 32.5% to $0.1829 after jumping over 59% on Wednesday. Loyalty Ventures recently announced bankruptcy filings and plans to delist from the Nasdaq Global Select Market.
    • Telos Corporation (NASDAQ:TLS) fell 30% to $2.24 after the company issued Q1 and FY23 revenue guidance below estimates.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) fell 27.8% to $2.0193.
    • The Honest Company, Inc. (NASDAQ:HNST) dropped 26.6% to $2.0407 after the company reported worse-than-expected Q4 EPS results.
    • Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) dropped 25.6% to $1.42 after posting a Q4 loss.
    • ToughBuilt Industries, Inc.. (NASDAQ:TBLT) fell 24.3% to $1.4084 after reporting Q4 results.
    • IDW Media Holdings, Inc. (NYSE:IDW) declined 21.2% to $0.63 after the company reported worse-than-expected Q1 EPS and sales results.
    • Tutor Perini Corporation (NYSE:TPC) fell 21% to $5.66 after the company reported worse-than-expected Q4 results.
    • PacWest Bancorp (NASDAQ:PACW) dipped 20.7% to $9.00.
    • Moolec Science SA (NASDAQ:MLEC) fell 18.9% to $4.88.
    • Titan Machinery Inc. (NASDAQ:TITN) fell 18.4% to $32.30 after the company reported worse-than-expected Q4 results and said the quarter was negatively impacted by delayed new equipment shipments.
    • Hello Group Inc. (NASDAQ:MOMO) dropped 18% to $6.89 after the company reported a 12.6% revenue decline and reported a decrease in monthly active users.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) fell 17.7% to $6.10.
    • Gossamer Bio, Inc. (NASDAQ:GOSS) dropped 17.6% to $1.0873.
    • Northwest Pipe Company (NASDAQ:NWPX) shares declined 16.7% to $30.33 following weak quarterly sales.
    • Tsakos Energy Navigation Limited (NYSE:TNP) fell 16.2% to $18.26 following Q4 results.
    • CN Energy Group. Inc. (NASDAQ:CNEY) fell 16.2% to $0.2092. CNEY recently announced pricing of $10 million underwritten public offering.
    • Western Alliance Bancorporation (NYSE:WAL) dropped 15% to $27.50 amid continued downward momentum in the sector following recent bank failures.
    • Ambipar Emergency Response (NYSE:AMBI) fell 14.1% to $7.91.
    • Burford Capital Limited (NYSE:BUR) shares dropped 13.2% to $6.66 after the company issued an update on its 2022 business activity.
    • First Foundation Inc. (NASDAQ:FFWM) dropped 11.7% to $8.32.
    • KeyCorp (NYSE:KEY) dipped 10.4% to $10.52.
    • Tredegar Corporation (NYSE:TG) fell 8.3% to $9.35 after reporting a decline in quarterly earnings.
    • JinkoSolar Holding Co., Ltd. (NYSE:JKS) dropped 6.9% to $44.87.

    Now Read This: Top 5 Tech Stocks Which You'll Regret Missing This Quarter

    Get the next $AMBI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMBI
    $BUR
    $CABA
    $CERT

    CompanyDatePrice TargetRatingAnalyst
    Burford Capital Limited
    $BUR
    3/30/2026$4.75Outperform → Neutral
    Wedbush
    JinkoSolar Holding Company Limited
    $JKS
    3/24/2026$28.50Sell → Buy
    Daiwa Securities
    Gossamer Bio Inc.
    $GOSS
    3/23/2026Overweight → Neutral
    Cantor Fitzgerald
    PagerDuty Inc.
    $PD
    3/13/2026Outperform → Mkt Perform
    William Blair
    EverCommerce Inc.
    $EVCM
    3/13/2026Mkt Outperform → Mkt Perform
    Citizens
    UiPath Inc.
    $PATH
    3/12/2026$15.00Hold → Buy
    Needham
    Western Alliance Bancorporation
    $WAL
    3/9/2026$83.00Buy → Hold
    TD Cowen
    Western Alliance Bancorporation
    $WAL
    3/9/2026$79.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $AMBI
    $BUR
    $CABA
    $CERT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMBI
    $BUR
    $CABA
    $CERT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Feierstein Matthew David

    4 - EverCommerce Inc. (0001853145) (Issuer)

    4/3/26 5:48:30 PM ET
    $EVCM
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Pedersen Leif E

    4 - Certara, Inc. (0001827090) (Issuer)

    4/3/26 4:11:56 PM ET
    $CERT
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Mckemey Adrian

    4 - Certara, Inc. (0001827090) (Issuer)

    4/3/26 4:10:24 PM ET
    $CERT
    Computer Software: Prepackaged Software
    Technology

    $AMBI
    $BUR
    $CABA
    $CERT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Burford Capital downgraded by Wedbush with a new price target

    Wedbush downgraded Burford Capital from Outperform to Neutral and set a new price target of $4.75

    3/30/26 8:16:51 AM ET
    $BUR
    Finance: Consumer Services
    Finance

    JinkoSolar upgraded by Daiwa Securities with a new price target

    Daiwa Securities upgraded JinkoSolar from Sell to Buy and set a new price target of $28.50

    3/24/26 8:27:29 AM ET
    $JKS
    Semiconductors
    Technology

    Gossamer Bio downgraded by Cantor Fitzgerald

    Cantor Fitzgerald downgraded Gossamer Bio from Overweight to Neutral

    3/23/26 8:26:50 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMBI
    $BUR
    $CABA
    $CERT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics

    Athyrium Funds purchased a portion of the royalties payable to Esperion on Japan net sales of Otsuka's bempedoic acid products, together with related milestone payments, subject to a cap, for total consideration of $50 millionAthyrium Funds to receive tiered royalties ranging from 12% to 33%, as well as milestone payments, until receiving aggregate payments equal to 2.0x their investment, after which all rights revert to EsperionFinancing supports Esperion's acquisition of Corstasis Therapeutics Inc., which developed and is commercializing Enbumyst™, the first FDA-approved intranasal loop diuretic for treatment of edema associated with cardiovascular and hepatic and renal disease NEW YORK a

    4/2/26 4:05:00 PM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

    – Enbumyst, First and Only FDA-Approved Nasal Spray Loop Diuretic Now Integrated into Esperion's Cardiovascular Franchise, Anticipated to Drive Portfolio Expansion, Commercial Leverage, and Continued Revenue Growth – ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) (the Company) today announced the closing of its acquisition of Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for the treatment of edema associated with cardiovascular and hepatic and renal disease. "The closing of this acquisition marks an important milestone in advancing our Vision 2040 and strengthens our commitm

    4/2/26 4:00:00 PM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Western Alliance Bank Earns Prestigious 2026 Portfolio Award from Financial Communications Society for Brand Unity Initiative

    Award recognizes Western Alliance Bank's transformation into a unified national commercial brand Western Alliance Bank (NYSE:WAL) today announced it has earned a 2026 Portfolio Award from the Financial Communications Society (FCS) for its successful Brand Unity initiative. In 2025, Western Alliance Bank completed a major strategic milestone with the rollout of Brand Unity, an enterprise-wide marketing and communications effort that clearly articulated why, how and when six division bank brands would align under the Western Alliance name. The initiative supported the bank's National Commercial Bank Strategy by delivering a more seamless, consistent brand experience for customers across t

    4/2/26 12:35:00 PM ET
    $WAL
    Major Banks
    Finance

    $AMBI
    $BUR
    $CABA
    $CERT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by First Foundation Inc.

    SCHEDULE 13D/A - First Foundation Inc. (0001413837) (Subject)

    4/3/26 4:05:27 PM ET
    $FFWM
    Major Banks
    Finance

    SEC Form DEFA14A filed by Certara Inc.

    DEFA14A - Certara, Inc. (0001827090) (Filer)

    4/3/26 6:04:32 AM ET
    $CERT
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEF 14A filed by Certara Inc.

    DEF 14A - Certara, Inc. (0001827090) (Filer)

    4/3/26 6:00:38 AM ET
    $CERT
    Computer Software: Prepackaged Software
    Technology

    $AMBI
    $BUR
    $CABA
    $CERT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Global Value Investment Corp. bought $286,122 worth of shares (82,355 units at $3.47) (SEC Form 4)

    4 - Fluent, Inc. (0001460329) (Issuer)

    3/16/26 9:55:04 PM ET
    $FLNT
    Advertising
    Consumer Discretionary

    Director Geygan James bought $286,556 worth of shares (82,480 units at $3.47), increasing direct ownership by 0.21% to 58,406 units (SEC Form 4)

    4 - Fluent, Inc. (0001460329) (Issuer)

    3/16/26 9:55:03 PM ET
    $FLNT
    Advertising
    Consumer Discretionary

    Director Arkley Peter bought $1,824,002 worth of shares (25,000 units at $72.96), increasing direct ownership by 13% to 216,717 units (SEC Form 4)

    4 - TUTOR PERINI CORP (0000077543) (Issuer)

    3/6/26 5:05:45 PM ET
    $TPC
    General Bldg Contractors - Nonresidential Bldgs
    Consumer Discretionary

    $AMBI
    $BUR
    $CABA
    $CERT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by KeyCorp

    SC 13D/A - KEYCORP /NEW/ (0000091576) ()

    1/5/94 12:00:00 AM ET
    $KEY
    Major Banks
    Finance

    Amendment: SEC Form SC 13G/A filed by Designer Brands Inc.

    SC 13G/A - Designer Brands Inc. (0001319947) (Subject)

    12/12/24 6:00:14 PM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMBI
    $BUR
    $CABA
    $CERT
    Financials

    Live finance-specific insights

    View All

    Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

    ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the year ended December 31, 2025 and provides a corporate update. Corporate Highlights from 4Q 2025 to date Initiated patient enrollment in the FINALE pivotal clinical trial evaluating FemBloc, advancing toward U.S. approval.Appointed Kenneth D. Eichenbaum, M.D., M.S.E., to the Board of Directors, strengthening leadership and strategic oversight.FemBloc permanent birth control system achieved certification under the Medical Device Single Au

    3/31/26 4:05:00 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    Designer Brands Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    Third consecutive quarter of improved top line rate of change in comparable sales and net salesFourth quarter consolidated gross margin increased 280 basis points year-over-yearFull year adjusted operating income significantly above high end of guidance2026 guidance reflects meaningful growth in profitabilityCOLUMBUS, Ohio, March 26, 2026 /PRNewswire/ -- Designer Brands Inc. (NYSE:DBI) (the "Company," "we," "us," "our," and "Designer Brands"), one of the world's largest designers, producers, and retailers of footwear and accessories, today announced financial results for the three months and year ended January 31, 2026.

    3/26/26 6:45:00 AM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    JinkoSolar to Report Fourth Quarter and Full Year 2025 Results on April 16, 2026

    SHANGRAO, China, March 24, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE:JKS), a global leader in clean energy technology, today announced that it plans to release its unaudited financial results for the fourth quarter and full year ended December 31, 2025 before the open of U.S. markets on Thursday, April 16, 2026. JinkoSolar's management will host an earnings conference call on Thursday, April 16, 2026 at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing / Hong Kong the same day).Please register in advance of the conference using the link provided below. Upon registering, you will be provided with participant dial-in numbers, passcode and unique acces

    3/24/26 6:00:00 AM ET
    $JKS
    Semiconductors
    Technology

    $AMBI
    $BUR
    $CABA
    $CERT
    Leadership Updates

    Live Leadership Updates

    View All

    Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

    ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of John Canning as Chief Operating Officer. Mr. Canning is an accomplished medical device executive with more than 25 years of experience leading global operations and technology organizations within complex medical device companies. He brings a track record of scaling organizations, advancing product pipelines, and driving operational excellence across key functions to support commercial growth and product adoption. Prior to joining

    4/1/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    Verde Clean Fuels, Inc. Announces New CEO and Engagement of Financial Advisor to Evaluate Strategic Alternatives

    George Burdette, current Chief Financial Officer, appointed Chief Executive Officer Roth Capital Partners retained as financial advisor to evaluate strategic alternatives, including potential merger or sale Verde Clean Fuels, Inc. (NASDAQ:VGAS) ("Verde" or the "Company") announced today the appointment of George Burdette as Chief Executive Officer ("CEO") and engagement of Roth Capital Partners ("Roth") as financial advisor to assist the Company in evaluating strategic alternatives. These announcements are part of the Company's continued advancement of its previously announced restructuring and cost reduction initiatives. Mr. Burdette succeeds Ernie Miller who is stepping down from h

    3/20/26 6:13:00 PM ET
    $FSLR
    $VGAS
    Semiconductors
    Technology
    Major Chemicals
    Industrials

    Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors

    ATLANTA, March 18, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of Kenneth D. Eichenbaum, M.D., M.S.E., to its Board of Directors. Dr. Eichenbaum is a board-certified anesthesiologist with clinical affiliations at Corewell Health William Beaumont University Hospital and Trinity Health Oakland Hospital, bringing deep clinical expertise and strategic insight developed through more than 20 years of evaluating biotechnology and medical device companies and advising investment firms. He completed a fel

    3/18/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $AMBI
    $BUR
    $CABA
    $CERT
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    What Does the Recent Purchase at Air Transport Services Group Inc on Jun 7 Indicate?

    Recently, on June 7, 2024, Michael L Berger, a significant figure at Air Transport Services Group Inc, made a notable insider purchase. Berger bought $49,830 worth of shares, acquiring 3,996 units at a price of $12.47 per share. This transaction increased his direct ownership by 4% to 103,705 units as reported in the SEC Form 4 here. Examining other insider actions within the company can sometimes reveal intriguing patterns that might offer insights for investors. Looking back at previous transactions, we see a series of insider activities at Air Transport Services Group Inc: In March 2024, Dominick Jeffrey A. filed an SEC Form 4, indicating a notable transaction date in which actions were

    6/10/24 12:35:45 AM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care